ReviewNeuro-oncology2018

The FDA NIH Biomarkers, EndpointS, and other Tools (BEST) resource in neuro-oncology.

Daniel N Cagney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.